Recent News

By Category: Research

PharmAthene Progresses Second Generation rPA Anthrax Vaccine

(Sacramento Bee) PharmAthene, Inc. announced today further development progress of its second generation rPA anthrax vaccine, SparVax™. The new vaccine is being developed to provide rapid manufacturing scale-up to respond to a national security emergency. The Company completed its first cGMP manufacturing run at 1,500 liter commercial scale. Final analytical testing is ongoing and expected  Read More »

Key To Anthrax Defense Could Be Natural Killer Cells

(Medical News Today) One of the things that makes inhalational anthrax so worrisome for biodefense experts is how quickly a relatively small number of inhaled anthrax spores can turn into a lethal infection…

Auditors See Shortcomings in U.S. Biodefense Drug Planning

(GSN Daily News) The U.S. Health and Human Services has failed to produce anticipated revisions to a 4-year-old plan on the preparation of medical products for responding to a biological strike by extremists, congressional auditors said in an assessment published last week (see GSN, Oct. 26). The Government Accountability Office said the department had yet  Read More »

Anthrax labs are secure, Battelle says

(Columbus Dispatch) Anthrax and other deadly biological agents at Battelle's West Jefferson labs are examined under strict security procedures that are intended to keep scientists and the public safe, officials with the research giant said today. …

GAO finds gaps in bioterror countermeasure planning, budgeting

(CIDRAP News) The US Department of Health and Human Services (HHS) has continued to modify its bioterror countermeasure priorities based on current risk assessments, but it hasn't updated formal plans or fleshed out budget priorities, …

« First...102030...294295296297298...310320330...Last »

Also filed under "Research":